Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam
Crossref DOI link: https://doi.org/10.1007/s11136-016-1483-3
Published Online: 2016-12-21
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mukuria, Clara http://orcid.org/0000-0003-4318-1481
Young, Tracey
Keetharuth, Anju
Borghs, Simon
Brazier, John
Funding for this research was provided by:
UCB Pharma
License valid from 2016-12-21